TCRX
TScan Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseOct 22, 2026 3:51:08 PM EDT
0.22USD-3.036%(-0.01)299,115
Loading…
Loading…
14.78M
Healthcare
Biotechnology
HQ
Waltham, MA, USA
136
Previous Close
$0.22
Beta
1.64
52-Week High
$2.43 2025-10-27
52-Week Low
$0.20 2026-10-14
SMA 50
$0.44
SMA 200
$0.89
Avg. Vol 10D
696,609
Avg. Vol 30D
721,747
Avg. Vol 90D
798,023
Relative Vol
0.41
67.78M
54.36M
80.20%
2,486,277
4.49%
3.25
35%/65%
63.18%
62.14%
0.9000%
1,100,000
2,286
7,618
14,974
Nov 11, 2026 (20d)
7.1M
-117.7M
-118.4M
-1,695.15
-95.8
TCRX Profile
harnessing novel t cell systems to extend the promise of immunotherapy
TCRX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.24 | 2026-10-15 | -8.90% | 1.396 |
| 1M | 0.35 | 2026-09-22 | -38.56% | 1.474 |
| 3M | 0.90 | 2026-07-22 | -75.77% | 0.779 |
| 6M | 1.25 | 2026-04-22 | -82.56% | 0.761 |
| 1Y | 2.24 | 2025-10-22 | -90.27% | 1.636 |
| 2Y | 5.24 | 2024-10-22 | -95.84% | — |
| 5Y | 7.79 | 2021-10-22 | -97.20% | 0.480 |
TCRX Stock Summary
TScan Therapeutics, Inc. Common Stock (NASDAQ:TCRX) stock price today is $0.22, and today's volume is 292,598. TCRX is down 2.679% today. The 30 day average volume is 721,747. TCRX market cap is $14.78M with 67.78M shares outstanding.